These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 36286976)

  • 1. [Composition of oropharyngeal microbiota in patients with COVID-19 of different pneumonia severity].
    Starikova EV; Galeeva JS; Andreev DN; Sokolov PS; Fedorov DE; Manolov AI; Pavlenko AV; Klimina KM; Veselovsky VA; Zaborovsky AV; Evdokimov VV; Andreev NG; Devkota MK; Fomenko AK; Khar'kovskii VA; Asadulin PO; Kucher SA; Cheremushkina AS; Yanushevich OO; Maev IV; Krikheli NI; Levchenko OV; Ilina EN; Govorun VM
    Ter Arkh; 2022 Oct; 94(8):963-972. PubMed ID: 36286976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of Altered Oropharyngeal Microbiota in Hospitalized Patients With Mild SARS-CoV-2 Infection.
    Shi YL; He MZ; Han MZ; Gui HY; Wang P; Yu JL; Ge YL; Sun Y; Huang SH
    Front Cell Infect Microbiol; 2022; 12():824578. PubMed ID: 35372134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limited Impact of SARS-CoV-2 on the Human Naso-Oropharyngeal Microbiota in Hospitalized Patients.
    Lai CKC; Cheung MK; Lui GCY; Ling L; Chan JYK; Ng RWY; Chan HC; Yeung ACM; Ho WCS; Boon SS; Chan PKS; Chen Z
    Microbiol Spectr; 2022 Dec; 10(6):e0219622. PubMed ID: 36350127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of Nasal/Oropharyngeal Microbial Community of COVID-19 Patients by 16S rDNA Sequencing.
    Rueca M; Fontana A; Bartolini B; Piselli P; Mazzarelli A; Copetti M; Binda E; Perri F; Gruber CEM; Nicastri E; Marchioni L; Ippolito G; Capobianchi MR; Di Caro A; Pazienza V
    Int J Environ Res Public Health; 2021 Feb; 18(4):. PubMed ID: 33672177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metagenomic analysis reveals oropharyngeal microbiota alterations in patients with COVID-19.
    Ma S; Zhang F; Zhou F; Li H; Ge W; Gan R; Nie H; Li B; Wang Y; Wu M; Li D; Wang D; Wang Z; You Y; Huang Z
    Signal Transduct Target Ther; 2021 May; 6(1):191. PubMed ID: 33986253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temporal dynamics of oropharyngeal microbiome among SARS-CoV-2 patients reveals continued dysbiosis even after Viral Clearance.
    Paine SK; Rout UK; Bhattacharyya C; Parai D; Alam M; Nanda RR; Tripathi D; Choudhury P; Kundu CN; Pati S; Bhattacharya D; Basu A
    NPJ Biofilms Microbiomes; 2022 Aug; 8(1):67. PubMed ID: 36002454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Long-Term Erythromycin Therapy on the Oropharyngeal Microbiome and Resistance Gene Reservoir in Non-Cystic Fibrosis Bronchiectasis.
    Choo JM; Abell GCJ; Thomson R; Morgan L; Waterer G; Gordon DL; Taylor SL; Leong LEX; Wesselingh SL; Burr LD; Rogers GB
    mSphere; 2018 Apr; 3(2):. PubMed ID: 29669883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns in the longitudinal oropharyngeal microbiome evolution related to ventilator-associated pneumonia.
    Sommerstein R; Merz TM; Berger S; Kraemer JG; Marschall J; Hilty M
    Antimicrob Resist Infect Control; 2019; 8():81. PubMed ID: 31139364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upper versus lower airway microbiome and metagenome in children with cystic fibrosis and their correlation with lung inflammation.
    Kirst ME; Baker D; Li E; Abu-Hasan M; Wang GP
    PLoS One; 2019; 14(9):e0222323. PubMed ID: 31536536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The characterization of bacterial communities of oropharynx microbiota in healthy children by combining culture techniques and sequencing of the 16S rRNA gene.
    Maleki A; Zamirnasta M; Taherikalani M; Pakzad I; Mohammadi J; Krutova M; Kouhsari E; Sadeghifard N
    Microb Pathog; 2020 Jun; 143():104115. PubMed ID: 32135220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 16S rRNA amplicon sequencing identifies microbiota associated with oral cancer, human papilloma virus infection and surgical treatment.
    Guerrero-Preston R; Godoy-Vitorino F; Jedlicka A; Rodríguez-Hilario A; González H; Bondy J; Lawson F; Folawiyo O; Michailidi C; Dziedzic A; Thangavel R; Hadar T; Noordhuis MG; Westra W; Koch W; Sidransky D
    Oncotarget; 2016 Aug; 7(32):51320-51334. PubMed ID: 27259999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Super Dominant Pathobiontic Bacteria in the Nasopharyngeal Microbiota Cause Secondary Bacterial Infection in COVID-19 Patients.
    Qin T; Wang Y; Deng J; Xu B; Zhu X; Wang J; Zhou H; Zhao N; Jin F; Ren H; Wang H; Li Q; Xu X; Guo Y; Li R; Xiong Y; Wang X; Guo J; Zheng H; Hou X; Wan K; Zhang J; Lu J; Kan B; Xu J
    Microbiol Spectr; 2022 Jun; 10(3):e0195621. PubMed ID: 35579467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upper Respiratory Dysbiosis with a Facultative-dominated Ecotype in Advanced Lung Disease and Dynamic Change after Lung Transplant.
    Simon-Soro A; Sohn MB; McGinniss JE; Imai I; Brown MC; Knecht VR; Bailey A; Clarke EL; Cantu E; Li H; Bittinger K; Diamond JM; Christie JD; Bushman FD; Collman RG
    Ann Am Thorac Soc; 2019 Nov; 16(11):1383-1391. PubMed ID: 31415219
    [No Abstract]   [Full Text] [Related]  

  • 15. Upper respiratory tract microbiota dynamics following COVID-19 in adults.
    Rosas-Salazar C; Kimura KS; Shilts MH; Strickland BA; Freeman MH; Wessinger BC; Gupta V; Brown HM; Boone HH; Rajagopala SV; Turner JH; Das SR
    Microb Genom; 2023 Feb; 9(2):. PubMed ID: 36820832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison Study of Oropharyngeal Microbiota in Case of Bronchial Asthma and Chronic Obstructive Pulmonary Disease in Different Severity Levels].
    Ogorodova LM; Fedosenko SV; Popenko AS; Petrov VA; Tyakht AV; Saltykova IV; Deev IA; Kulikov ES; Kirillova NA; Govorun VM; Kostryukova ES
    Vestn Ross Akad Med Nauk; 2015; (6):669-78. PubMed ID: 27093794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metagenomic identification of gut microbiota distribution on the colonic mucosal biopsy samples in patients with non-alcoholic fatty liver disease.
    Delik A; Dinçer S; Ülger Y; Akkız H; Karaoğullarından Ü
    Gene; 2022 Jul; 833():146587. PubMed ID: 35598686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing microbiotas in the upper aerodigestive and lower respiratory tracts of lambs.
    Glendinning L; Collie D; Wright S; Rutherford KMD; McLachlan G
    Microbiome; 2017 Oct; 5(1):145. PubMed ID: 29078799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The concordance between upper and lower respiratory microbiota in children with Mycoplasma pneumoniae pneumonia.
    Dai W; Wang H; Zhou Q; Feng X; Lu Z; Li D; Yang Z; Liu Y; Li Y; Xie G; Shen K; Yang Y; Zheng Y; Li S
    Emerg Microbes Infect; 2018 May; 7(1):92. PubMed ID: 29789582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amplicon Sequence Variants Artificially Split Bacterial Genomes into Separate Clusters.
    Schloss PD
    mSphere; 2021 Aug; 6(4):e0019121. PubMed ID: 34287003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.